What is Spatial Metabolomics (MSI)
Spatial metabolomics uses mass spectrometry imaging (MSI—e.g., MALDI, DESI, nano-DESI) to map
where metabolites, lipids, and xenobiotics reside directly on tissue sections at
micrometer-scale pixel sizes. Instead of averaging signals from homogenized extracts, MSI preserves tissue
architecture and produces ion images—two-dimensional molecular maps—co-registered to
brightfield/H&E for region-of-interest (ROI) analysis. Typical study parameters include:
- Pixel size (spatial resolution): ~10–200 µm (selected per objective and matrix).
- m/z range: ~50–1,500 for small molecules and lipids.
- Ionization: positive and negative modes; matrix/solvent chemistry tuned per analyte
class.
- Data outputs: imzML + vendor raw files, ROI statistics tables, pathway summaries, and
publication-ready images.
Compatible sample types include fresh-frozen tissues, selected FFPE (lipid-focused and defined metabolite
classes), organoids/spheroids, microbial biofilms, and plant/food matrices (method dependent).
Why Choose Spatial Metabolomics for Your Research
Which Spatial Metabolomics Platform Fits Your Research?
Not all MSI platforms are equivalent. The table below compares the three methods we offer across the
dimensions that matter for experimental design: spatial resolution, analyte coverage, sample prep
requirements, and workflow fit.
| Dimension |
MALDI-MSI |
DESI-MSI |
Nano-DESI |
| Spatial resolution |
10-50 um (down to 5 um on timsTOF) |
50-200 um |
10-50 um (capillary-controlled) |
| Analyte coverage |
Lipids, primary metabolites, peptides; broad coverage with matrix selection |
Lipids, drug compounds, small metabolites; ambient ionization, minimal fragmentation |
Polar metabolites, neurotransmitters, TCA intermediates; high sensitivity for low-abundance
targets |
| Sample prep |
Matrix application required (DHB, CHCA, DAN); tissue section mounted on ITO slide |
Minimal to none -- ambient ionization directly from tissue surface |
Liquid extraction via capillary bridge; minimal prep, well-suited for FFPE and delicate tissues
|
| Best for |
High-res lipidomics, boundary mapping, large-area tissue screening |
Rapid lipid profiling, FFPE-compatible workflows, drug distribution studies |
Targeted polar metabolites, neurochemical mapping, low-abundance compound imaging |
| Throughput |
High -- up to 50 pixels/sec at 50 um; automated acquisition |
Moderate -- solvent flow rate limits speed |
Lower -- capillary bridge limits acquisition speed; best for ROI-focused studies |
Not sure which platform fits your tissue type and research question? Contact us during study design -- we will recommend the optimal method or a multi-platform approach based on your sample and target analytes.
Why Now Is the Right Time to Use Spatial Metabolomics
- Mature imaging performance: Micrometer-scale pixel sizes with high mass accuracy (ppm-level on
high-resolution analyzers), dual-polarity acquisition, and lock-mass/internal-calibrant workflows deliver
reproducibility suitable for decision-grade research.
- Expanded chemical coverage: On-tissue derivatization (carbonyls, amines, carboxylates) and optimized
matrices/solvents improve detection of difficult metabolite classes.
- Standardized, auditable pipelines: imzML-centered workflows support peak picking, deisotoping/adduct
deconvolution, recalibration, normalization, annotation, and pathway enrichment with transparent QC.
- Broader sample compatibility & throughput: Robust methods for fresh-frozen, selected FFPE
(lipid-forward and defined metabolite classes), organoids, and complex matrices enable consistent
sectioning, prep, and imaging at study scale.
- Actionable deliverables: Clear ROI effect sizes and pathway panels shorten time from raw images to
interpretable insights; assets export cleanly to common analytics environments.
What You Can Accomplish with This Service?
- Map microenvironments with micrometer precision to reveal gradients and borders that guide
hypothesis refinement.
- Differentiate molecular phenotypes between ROIs (e.g., core vs. periphery, interface zones,
treatment vs. control) with statistics suitable for reports and submissions.
- Prioritize program targets by linking localized metabolite patterns to pathways and phenotypes.
- Reduce project risk by flagging off-region accumulation of small molecules and lipid remodeling
early.
- Elevate documentation with reproducible ion images, ROI statistics, and exportable analysis
artifacts.
Typical Questions We Answer
Which metabolites or lipids are enriched at defined ROIs?
Do energy or redox metabolite gradients exist across a boundary?
How does a compound or genetic perturbation remodel the local metabolome?
Which pathways are spatially co-activated or mutually exclusive?
Service Scope and Key Differentiators in Our Spatial Metabolomics Analysis
- Multi-platform MSI: MALDI-MSI for broad coverage and high throughput; DESI-MSI for
minimal prep; nano-DESI for enhanced sensitivity on select targets.
- Dual-polarity acquisition to maximize coverage of lipids, primary metabolites,
xenobiotics, and secondary metabolites.
- On-tissue chemistry options (derivatization for carbonyls, amines, and carboxylates;
matrix selection tailored to analyte classes).
- Targeted + untargeted pipelines with library and formula-based annotation, isotopolog
detection, and adduct deconvolution.
- Quantitative region statistics with multiple normalization strategies (TIC, internal
calibrants, ROI-specific).
- Regimented QC: section-to-section alignment, lock-mass correction, batch monitors, and
drift control with calibrant arrays.
- Rich deliverables: imzML and vendor files, ion images, ROI maps, annotated feature
tables, pathway overlays, and analysis notebooks.
Technology Platforms and Analytical Parameters for Spatial Metabolomics
Mass spectrometry imaging platforms
- MALDI-MSI (Orbitrap/FT-ICR/TOF): broad metabolite & lipid coverage, fast scanning.
- DESI-MSI / nano-DESI: ambient ionization; ideal for delicate or limited-prep samples.
Typical operating ranges (customizable by study)
- Spatial resolution (pixel size): ~10–200 µm (study-dependent).
- Section thickness: ~5–20 µm for frozen tissue; FFPE thickness per method.
- Mass range (m/z): ~50–1,500 (expandable with method).
- Mass accuracy: down to low-ppm on high-resolution platforms with internal/lock mass.
- Ionization modes: positive and negative; adduct engineering where relevant.
- Matrices (MALDI examples): CHCA, DHB, 9-AA, DAN, and analyte-specific formulations.
- Normalization: TIC, RMS, internal standards, or histology-guided strategies.
- File formats: imzML + native vendor formats; processed outputs in CSV/Parquet; figures
in PNG/TIFF/SVG.
Guidance on Choosing the Right Spatial Metabolomics Method for Your Study
Why Choose Our Spatial Metabolomics Services
- Multi-Platform MSI Under One Roof
MALDI-MSI, DESI-MSI, and nano-DESI are all available in-house -- no subcontracting, no fragmented data packages. We select the right platform (or combination) for your tissue type and research question, not the one we happen to own.
- Quantitative, Not Just Pretty Pictures
Every ion map is backed by ROI-specific quantification with TIC normalization, internal calibrant correction, and batch-level QC. You receive concentration heatmaps and comparative statistics -- not just uncalibrated intensity images.
- Histology-Co-Registered for Biological Context
H&E or IF images are aligned to ion maps at the pixel level, identifying which tissue compartments (cortex vs. medulla, tumor vs. stroma, lesion vs. adjacent normal) correspond to each metabolic signature.
- Open-Format Data Delivery
All data delivered in imzML (open standard) plus vendor-native formats, enabling downstream analysis in SCiLS Lab, Cardinal, METASPACE, or your preferred bioinformatics pipeline -- no proprietary lock-in.
Step-by-Step Workflow of Our Spatial Metabolomics Analysis Service
Sample Types We Support
| Sample Type |
Description / Notes |
| Fresh-frozen tissues |
Mammalian, plant, microbial consortia, xenografts; embedded in OCT or equivalent |
| FFPE sections |
Lipid-focused MSI and select metabolite panels; optimized deparaffinization and antigen retrieval
as appropriate |
| Organoids & spheroids |
Includes 3D cultures; prepared for sectioning and MSI imaging |
| Microbial biofilms |
Suitable for spatial metabolomics of microbial communities |
| Tissue microarrays (TMAs) |
Multiplexed ROI analysis possible |
| Materials science samples |
Method permitting; matrix-dependent optimization |
| Food matrices |
Method permitting; compatibility evaluated during project design |
For detailed preparation and shipping guidelines, please contact our team before sending samples.
Quality Assurance You Can Audit
We implement rigorous, transparent QC protocols to ensure data accuracy, reproducibility, and traceability:
- Lock-mass & Internal Calibrants — Applied to every batch and slide set for consistent mass accuracy.
- Replicate Regions & Check Slides — Precision assessment through repeated ROI analysis.
- Background Controls — Blank regions and matrix-only slides to monitor noise and adduct formation.
- Carryover Checks — Inter-tile and inter-slide controls to detect contamination.
- Acceptance Criteria — Defined thresholds for mass accuracy, spatial fidelity, pixel completeness, and
S/N ratio.
- Change-Controlled Methods — Any procedural deviations are fully documented in the final report.
Data Analysis, Bioinformatics, and Reporting Deliverables
- Ion images for prioritized features (publication-ready).
- ROI-level tables (mean, median, variance, effect sizes, FDR-controlled p-values).
- Quantitation Approaches
- Relative quantitation with normalization and batch controls
- Absolute/semi-absolute quantitation using stable-isotope standards (feasibility dependent)
- Drift/batch correction via calibrant arrays and pooled slides
- Spatial stats (co-localization matrices, gradient analysis, neighborhood enrichment).
- Pathway panels summarizing localized pathway activity trends.
- Audit-ready methods: instrument settings, calibration details, matrix recipes, derivatization protocols,
and QC metrics.
- All raw & processed data (imzML, vendor raw, peak lists, metadata JSON) for downstream re-analysis.
Customizable Specifications for Your Spatial Metabolomics Study
| Dimension |
Option Set (examples) |
| Pixel size |
~10, 25, 50, 100, 200 µm (trade-off vs. sensitivity & coverage) |
| Polarity |
Positive, Negative, Sequential Dual |
| Mass analyzer |
Orbitrap, FT-ICR, TOF (study-dependent) |
| m/z range |
~50–1,500 (custom windows possible) |
| Matrices |
CHCA, DHB, 9-AA, DAN; custom blends |
| Derivatization |
Carbonyl-, amine-, or carboxyl-targeted chemistries |
| Normalization |
TIC, internal standard, ROI-specific |
| Deliverables |
imzML + raw, ion images, ROI stats, pathway summaries, methods dossier |
Getting Started: What We Need from You
- Study objective and hypotheses; target metabolites/classes if known.
- Sample list, matrix, storage conditions, and any prior staining or treatments.
- Preferred pixel size, ROI definitions, and required statistics or comparisons.
- Any constraints on sample consumption or serial-section usage.
We'll propose a fit-for-purpose design with clear acceptance criteria, an
instrument/chemistry plan, and data/figure deliverables aligned to your milestones.